Next Article in Journal
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria
Next Article in Special Issue
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Previous Article in Journal
Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency
Previous Article in Special Issue
Harnessing Immunity to Treat Advanced Thyroid Cancer
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Review

Article Versions Notes

Vaccines 2024, 12(2), 165; https://doi.org/10.3390/vaccines12020165
Action Date Notes Link
article html file updated 25 June 2025 11:57 CEST Update https://www.mdpi.com/2076-393X/12/2/165/html
article html file updated 6 February 2024 09:58 CET Update -
article pdf uploaded. 6 February 2024 09:57 CET Updated version of record https://www.mdpi.com/2076-393X/12/2/165/pdf
article xml uploaded. 6 February 2024 09:57 CET Update https://www.mdpi.com/2076-393X/12/2/165/xml
article xml file uploaded 6 February 2024 09:57 CET Update -
article html file updated 6 February 2024 09:17 CET Update -
article html file updated 6 February 2024 09:16 CET Update -
article html file updated 6 February 2024 09:15 CET Update -
article pdf uploaded. 6 February 2024 09:13 CET Updated version of record -
article xml uploaded. 6 February 2024 09:13 CET Update -
article xml file uploaded 6 February 2024 09:13 CET Update -
article html file updated 6 February 2024 07:43 CET Original file -
article pdf uploaded. 6 February 2024 07:41 CET Version of Record -
article xml uploaded. 6 February 2024 07:41 CET Update -
article xml file uploaded 6 February 2024 07:41 CET Original file -
Back to TopTop